blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2554169

EP2554169 - PHARMACEUTICAL PREPARATION COMPRISING PHENYLALANINE DERIVATIVE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.09.2020
Database last updated on 16.07.2024
FormerThe patent has been granted
Status updated on  18.10.2019
FormerGrant of patent is intended
Status updated on  22.07.2019
FormerExamination is in progress
Status updated on  13.10.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
EA Pharma Co., Ltd.
2-1-1, Irifune
Chuo-ku
Tokyo 104-0042 / JP
[2016/34]
Former [2013/06]For all designated states
Ajinomoto Co., Inc.
15-1, Kyobashi 1-chome Chuo-ku
Tokyo 104-8315 / JP
Inventor(s)01 / ABURATANI, Satoshi
c/o Ajinomoto Pharmaceuticals Co. Ltd.
1-1 Suzuki-cho
Kawasaki-ku
Kawasaki-shi Kanagawa 210-0801 / JP
02 / HAGIO, Hirokazu
c/o Ajinomoto Pharmaceuticals Co. Ltd.
1-1 Suzuki-cho
Kawasaki-ku
Kawasaki-shi Kanagawa 210-0801 / JP
03 / HIGUCHI, Hiroyuki
c/o Ajinomoto Pharmaceuticals Co. Ltd.
1-1 Suzuki-cho
Kawasaki-ku
Kawasaki-shi Kanagawa 210-0801 / JP
04 / OGAWA, Kenichi
c/o Ajinomoto Pharmaceuticals Co. Ltd.
1-1, Suzuki-cho, Kawasaki-ku
Kawasaki-shi Kanagawa 2100801 / JP
 [2019/47]
Former [2013/06]01 / ABURATANI Satoshi
c/o Ajinomoto Pharmaceuticals Co. Ltd.
1-1 Suzuki-cho
Kawasaki-ku
Kawasaki-shi Kanagawa 210-0801 / JP
02 / HAGIO Hirokazu
c/o Ajinomoto Pharmaceuticals Co. Ltd.
1-1 Suzuki-cho
Kawasaki-ku
Kawasaki-shi Kanagawa 210-0801 / JP
03 / HIGUCHI Hiroyuki
c/o Ajinomoto Pharmaceuticals Co. Ltd.
1-1 Suzuki-cho
Kawasaki-ku
Kawasaki-shi Kanagawa 210-0801 / JP
04 / OGAWA Kenichi
c/o Ajinomoto Pharmaceuticals Co. Ltd.
1-1, Suzuki-cho, Kawasaki-ku
Kawasaki-shi Kanagawa 2100801 / JP
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[N/P]
Former [2019/47]Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Former [2013/06]Nicholls, Kathryn Margaret, et al
Mewburn Ellis LLP 33 Gutter Lane London
EC2V 8AS / GB
Application number, filing date11762844.629.03.2011
[2019/47]
WO2011JP57799
Priority number, dateJP2010007474029.03.2010         Original published format: JP 2010074740
[2013/06]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011122620
Date:06.10.2011
Language:JA
[2011/40]
Type: A1 Application with search report 
No.:EP2554169
Date:06.02.2013
Language:EN
[2013/06]
Type: B1 Patent specification 
No.:EP2554169
Date:20.11.2019
Language:EN
[2019/47]
Search report(s)International search report - published on:JP06.10.2011
(Supplementary) European search report - dispatched on:EP11.04.2014
ClassificationIPC:A61K9/20, A61K9/32, A61K47/32, A61K31/517, A61P29/00
[2014/20]
CPC:
A61K31/517 (EP,CN,US); A61K47/32 (CN); A61K9/2027 (EP,US);
A61K9/2054 (EP,US); A61K9/2059 (CN); A61K9/2077 (US);
A61K9/284 (CN); A61K9/2853 (CN); A61K9/286 (CN);
A61K9/2866 (CN,US); A61K9/2873 (CN); A61P1/00 (EP);
A61P29/00 (EP) (-)
Former IPC [2013/06]A61K31/517, A61K9/32, A61K47/26, A61K47/32, A61K47/36, A61K47/38, A61P1/00, A61P29/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/06]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:PHARMAZEUTISCHES PRÄPARAT MIT EINEM PHENYLALANINDERIVAT[2013/06]
English:PHARMACEUTICAL PREPARATION COMPRISING PHENYLALANINE DERIVATIVE[2013/06]
French:PRÉPARATION PHARMACEUTIQUE COMPRENANT UN DÉRIVÉ DE PHÉNYLALANINE[2013/06]
Entry into regional phase11.10.2012Translation filed 
16.10.2012National basic fee paid 
16.10.2012Search fee paid 
16.10.2012Designation fee(s) paid 
16.10.2012Examination fee paid 
Examination procedure16.10.2012Examination requested  [2013/06]
05.11.2014Amendment by applicant (claims and/or description)
17.10.2017Despatch of a communication from the examining division (Time limit: M04)
27.02.2018Reply to a communication from the examining division
23.07.2019Communication of intention to grant the patent
09.10.2019Fee for grant paid
09.10.2019Fee for publishing/printing paid
09.10.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.10.2017
Opposition(s)21.08.2020No opposition filed within time limit [2020/44]
Fees paidRenewal fee
11.03.2013Renewal fee patent year 03
12.03.2014Renewal fee patent year 04
10.03.2015Renewal fee patent year 05
10.03.2016Renewal fee patent year 06
10.03.2017Renewal fee patent year 07
13.03.2018Renewal fee patent year 08
13.03.2019Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.03.2011
AL20.11.2019
AT20.11.2019
CY20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
MK20.11.2019
MT20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
TR20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
IE29.03.2020
LU29.03.2020
BE31.03.2020
CH31.03.2020
LI31.03.2020
PT12.04.2020
[2022/32]
Former [2022/27]HU29.03.2011
AL20.11.2019
AT20.11.2019
CY20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
MT20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
TR20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
IE29.03.2020
LU29.03.2020
BE31.03.2020
CH31.03.2020
LI31.03.2020
PT12.04.2020
Former [2022/26]AL20.11.2019
AT20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
TR20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
IE29.03.2020
LU29.03.2020
BE31.03.2020
CH31.03.2020
LI31.03.2020
PT12.04.2020
Former [2021/12]AL20.11.2019
AT20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
IE29.03.2020
LU29.03.2020
BE31.03.2020
CH31.03.2020
LI31.03.2020
PT12.04.2020
Former [2021/08]AL20.11.2019
AT20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
IE29.03.2020
LU29.03.2020
CH31.03.2020
LI31.03.2020
PT12.04.2020
Former [2021/04]AL20.11.2019
AT20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
LU29.03.2020
PT12.04.2020
Former [2020/51]AL20.11.2019
AT20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/49]AL20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SK20.11.2019
SM20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/37]AL20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SK20.11.2019
SM20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/36]AL20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/35]AL20.11.2019
CZ20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/32]AL20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RS20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/26]FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RS20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/24]FI20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/23]FI20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
Former [2020/22]FI20.11.2019
LT20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
Former [2020/21]NO20.02.2020
Documents cited:Search[Y]US2006127475  (MAKINO CHISATO [JP], et al) [Y] 1-11 * page 1, paragraphs 0002-0011 ** example - *;
 [Y]EP1683524  (AJINOMOTO KK [JP]) [Y] 1-11 * page 10, paragraph 0025 - page 13, paragraph 0042 * * example - *;
 [Y]  - Crospovidone ED - Rowe Raymond C; Sheskey Paul J; Weller Paul J, HANDBOOK OF PHARMACEUTICAL EXCIPIENTS, PHARMACEUTICAL PRESS, LONDON, UK, PAGE(S) 184, (20021126), ISBN 978-0-85369-537-0, XP002719370 [Y] 1-11 * page 184, paragraph 7 *
International search[Y]WO2005046696  (AJINOMOTO KK [JP], et al);
 [Y]  - Handbook of Pharmaceutical Excipients, (2007), pages 280 - 282, XP008158241
 [Y]  - IYAKUHIN TENKABUTSU JITEN 2007, (2007), page 93, XP008158254
by applicantWO0216329
 WO2004074264
 WO2005046696
 WO2005046697
 WO2005051925
    - J. PHARM. SCI., (1971), vol. 60, no. 9, pages 1281 - 1302
    - Japanese Pharmacopoeia
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.